VIR Vir Biotechnology, Inc.
P/E
--
Forward P/E
4.272
Price/Sales
5.9
Beta
1.593
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Vir Biotechnology's third quarter 2026 loss narrowed to $0.57 per share beating analyst expectations
Vir Biotechnology reported a narrower-than-expected net loss of $96.3 million for the third quarter of 2026, compared to a $163.1 million loss in the prior...
Vir Biotechnology Inc Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Consensus estimates for Vir Biotechnology point to a Q3 2026 revenue of approximately $0.86 million and an EPS loss of $0.74, while the stock currently trades...